# FDA recall D-0957-2017

> **Baxter Healthcare Corporation** · Class II · drug recall initiated 2017-07-06.

## Product

0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL  60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02.

## Reason for recall

Lack of Assurance of Sterility: Customer complaints for leaking bags.

## Distribution

Nationwide in USA

## Key facts

- **Recall number:** D-0957-2017
- **Recalling firm:** Baxter Healthcare Corporation
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-07-06
- **Report date:** 2017-07-19
- **Termination date:** 2020-04-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Deerfield, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0957-2017

## Citation

> AI Analytics. FDA recall D-0957-2017. Retrieved 2026-07-04 from https://api.ai-analytics.org/recall/D-0957-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*